The fastest-growing customer in supplements right now isn’t looking for weight-loss pills — they’re already on a GLP-1 drug and looking for everything the drug doesn’t give them. As GLP-1 use expands, demand is rising for companion nutrition that supports long-term treatment outcomes — protein to protect muscle, fiber and electrolytes to manage side effects, micronutrients to fill the gaps.
For brand owners, GLP-1 companion formulas are one of the clearest 2026 opportunities — if you formulate them responsibly. Here’s how.
GLP-1 medications suppress appetite, which is the point — and also the problem. Users eat far less, which puts muscle mass, protein intake, hydration, and micronutrient status at risk. A companion product doesn’t replace or mimic the drug. It fills the nutritional gaps the reduced intake creates, in formats a person with low appetite can actually tolerate.
That framing matters legally and commercially: you are supporting nutrition during treatment, not making a drug claim.
| Component | Why It Matters for GLP-1 Users |
|---|---|
| High-quality protein | Preserves lean muscle during rapid appetite suppression |
| Fiber (soluble + prebiotic) | Supports digestion and helps manage common GI side effects |
| Electrolytes | Counter dehydration when food and fluid intake drop |
| Key micronutrients | Fill gaps left by sharply reduced overall intake |
This is the part brands underestimate. A GLP-1 user with a suppressed appetite cannot drink a large, dense protein shake. The format has to respect that.
The brands winning here are designing for the physiology of the user, not repackaging a standard mass-gainer.
The category is crowded with products implying they replace or rival the drug. That’s where regulators look. Keep your positioning clean:
Responsible positioning isn’t just compliance — it’s the trust that keeps a brand on retailer shelves as the category matures.
A product designed to fill the nutritional gaps created by appetite suppression during GLP-1 treatment — typically protein, fiber, electrolytes, and micronutrients in easy-to-tolerate, low-volume formats. It supports nutrition; it doesn’t replace the medication.
Compact, nutrient-dense formats — small protein shots, stick packs, and concentrated servings — because a suppressed appetite makes large, dense shakes hard to consume.
No. Claiming to replace or rival a GLP-1 drug invites regulatory action. Position the product as nutritional support during treatment, using structure/function language and the required disclaimer.
Building for the GLP-1 wave? UniWell Labs formulates protein, fiber, and electrolyte companion products in compact, tolerable formats — with compliant positioning built in. Talk to our team about your companion line.